Soc. Generale Call 26 FRE 21.03.2.../ DE000SV9V2B2 /
1/24/2025 9:09:24 AM | Chg.-0.010 | Bid9:14:54 AM | Ask9:14:54 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.100EUR | -0.90% | 1.100 Bid Size: 35,000 |
1.110 Ask Size: 35,000 |
FRESENIUS SE+CO.KGAA... | 26.00 - | 3/21/2025 | Call |
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil